Where Trial Optimization, Quality and Innovation Meet
Accelerate study start-up, improve protocol design, and reduce costs with strategies that drive patient engagement, decentralized trials, and AI-powered innovation. Stay ahead of regulatory changes while fostering quality and collaboration to deliver therapies faster.
Fierce Biotech Week 2026
May 12-14th
Early Bird Savings: Save $1,000 through March 20th
Who Will You Be Joining?
Here's a small sample of attendees:
Associate Director, Clinical Operations, Anavex Life Sciences
AD RDQ, BeOne Medicines
Senior Clinical Research Coordinator, Montefiore Medical Center / Albert Einstein College
Medical Director, MingSight Pharmaceuticals Inc
Sr Engr, Alexion
Director of Operations & Project Mgt Translational, AstraZeneca
Director-Digital & Data Strategy, AbbVie
Vice President Global Supply Chain, Zenas Bio
Sr. Director, Quality Assurance, GondolaBio
Director, Clinical QA, Tarsus Pharmaceuticals, Inc.
Associate Director, Quality Assurance, Tarsus Pharmaceuticals
Associate Director, Compliance, Tarsus Pharmaceutical
Sr Compliance Manager, Takeda
Head, DD&T Design & Delivery, R&D and Regulatory, Takeda
Investor, McKesson Ventures
Field Access Manager, Rhythm Pharmaceuticals
Senior Vice President Global Clinical Operations, ILIAD Biotechnologies
Associate Director Global Clinical Operations, ILiAD Biotechnologies
Global Head Scientific Publications & Data Sharing, Sanofi
CEO, Coharts Inc
CMO, ILiAD Biotechnologies
Clinical Operations Exec. Director, ILiAD Biotechnologies
Senior Medical Director, Regeneron Pharmaceuticals
Lead, Innovator Growth Division, Mass General Brigham
VP/GM Healthcare Analytics Solutions, Quest Diagnostics Inc.
Sr. Director, Operational Excellence, Intellia Therapeutics
Chief Medical Officer and Vice President, Johnson and Johnson MedTech
Director, Business Operations GCOE, BeOne Medicines
Manager, Research Operations, Boston Children's Hospital
Senior Director, Head of Clinical Operations, Tris Pharma Inc.
Director, Gilead
Chief Business Officer, Immunic Therapeutics
Director, Field Operations, Ultragenyx
What’s Next in Clinical & TMF
Innovation in trial execution, strategic operational investment, and measurable regulatory impact.
The Leaders Delivering Clinical Impact
Key Topics for Clinical & TMF:
Advancing Patient-Centric Trial Design
Reimagining Site–Sponsor Partnerships
AI in Clinical Operations
Inspection Readiness in the ICH E6(R3) Era
Integrated Risk Management Across Clinical Teams
